These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7788172

  • 21. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
    Pullar T, Hunter JA, Capell HA.
    Ann Rheum Dis; 1985 Dec; 44(12):831-7. PubMed ID: 2867746
    [Abstract] [Full Text] [Related]

  • 22. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH, van Riel PL, van de Putte LB, Gribnau FW.
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [Abstract] [Full Text] [Related]

  • 23. [Statins and autoimmunity].
    Alvarado Cárdenas M, Marín Sánchez A, Lima Ruiz J, en representación del Grupo para estudio de Autoinmunidad y Estatinas.
    Med Clin (Barc); 2015 Nov 06; 145(9):399-403. PubMed ID: 25662717
    [Abstract] [Full Text] [Related]

  • 24. Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.
    Bax DE, Greaves MS, Amos RS.
    Br J Rheumatol; 1986 Aug 06; 25(3):282-4. PubMed ID: 2873862
    [Abstract] [Full Text] [Related]

  • 25. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE, Amos RS.
    Ann Rheum Dis; 1986 Feb 06; 45(2):139-40. PubMed ID: 2868699
    [Abstract] [Full Text] [Related]

  • 26. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T, Capell HA.
    Drugs; 1986 Feb 06; 32 Suppl 1():54-7. PubMed ID: 2877854
    [Abstract] [Full Text] [Related]

  • 27. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA, McConkey B.
    Scand J Rheumatol; 1985 Feb 06; 14(3):265-70. PubMed ID: 2864741
    [Abstract] [Full Text] [Related]

  • 28. Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis.
    Kitas GD, Farr M, Waterhouse L, Bacon PA.
    Scand J Rheumatol; 1992 Feb 06; 21(5):220-5. PubMed ID: 1359635
    [Abstract] [Full Text] [Related]

  • 29. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
    Wijnands MJ, Van 'T Hof MA, Van De Putte LB, Van Riel PL.
    Br J Rheumatol; 1993 Apr 06; 32(4):313-8. PubMed ID: 8096419
    [Abstract] [Full Text] [Related]

  • 30. Sulphasalazine-induced lupus syndrome in ulcerative colitis.
    Griffiths ID, Kane SP.
    Br Med J; 1977 Nov 05; 2(6096):1188-9. PubMed ID: 22375
    [No Abstract] [Full Text] [Related]

  • 31. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH, Scott DL, Kingsley GH, Williams P, Wojtulewski J, Papasavvas G, Henderson E, Macfarlane D, Erhardt C, Young A, Plant MJ, Panayi GS.
    Clin Exp Rheumatol; 2002 Nov 05; 20(3):351-8. PubMed ID: 12102471
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine.
    Farr M, Scott DG, Bacon PA.
    Drugs; 1986 Nov 05; 32 Suppl 1():49-53. PubMed ID: 2877853
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.